Related Experiment Video
Updated: Jun 14, 2025

07:39
Mouse In Vivo Placental Targeted CRISPR Manipulation
Published on: April 14, 2023
2.5K
Against epigenetic responsibility: The problem of causality in 'foetal programming' science
Courtney McMahon1, Catherine Mills1
1Faculty of Arts, Monash Bioethics Centre, Monash University, Clayton, Victoria, Australia.
Bioethics
|September 6, 2024
Summary
Prospective mothers may not have a moral responsibility for their offspring's epigenetics. Current fetal programming research lacks sufficient evidence to establish a causal link between intrauterine exposures and long-term health risks.
Area of Science:
- Environmental epigenetics
- Reproductive ethics
- Developmental toxicology
Background:
- Intrauterine environmental exposures may program offspring epigenetics, raising concerns about maternal moral responsibility.
- Existing proposals for maternal epigenetic responsibility often overlook the scientific uncertainty regarding causality.
Purpose of the Study:
- To evaluate the causal evidence linking intrauterine exposures to offspring epigenetic modifications and health outcomes.
- To assess whether current fetal programming research sufficiently establishes causality to ground claims of maternal moral responsibility.
Main Methods:
- Critical analysis of existing human fetal programming research.
- Examination of the challenges in establishing causal relationships in epigenetic studies.
- Philosophical inquiry into the conditions for moral responsibility.
Main Results:
- Much human fetal programming research has not yet established a definitive causal epigenetic link between intrauterine exposures and subsequent offspring health.
- Significant challenges persist in demonstrating the causal significance of prenatal exposures for long-term health outcomes.
Conclusions:
- The current lack of established causality in fetal programming research significantly weakens the argument for prospective mothers having a moral responsibility for their offspring's epigenetics.
- Further rigorous research is needed to establish causal links before moral claims can be substantiated.
Related Concept Videos
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Introduction to Nuclear Reprogramming
1.9K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.9K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K

